Evidence map›Paper›PMID 7642715›Full record

ArticleThe Journal of cell biology1995

Hst-1 (FGF-4) antisense oligonucleotides block murine limb development.

T Ochiya, H Sakamoto, M Tsukamoto, T Sugimura, M Terada

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Apoptosis in the chick wing bud and the permanence of FGF-2 rescue.In vitro cellular & developmental biology. Animal · 1998
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

T OchiyaGenetics Division, National Cancer Center Research Institute, Tokyo, Japan.
H Sakamoto
M Tsukamoto
T Sugimura
M Terada

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The initiation of limb development depends on the site specific proliferation of the mesenchyme by the signals from the apical ectodermal ridge (AER) in embryonic mouse. We have previously reported that the local expression of Hst-1/Fgf-4 transcripts in AER of the mouse limb bud is developmentally regulated, expressed at 11 and 12 days post coitus (p.c.) embryo. In an effort to further understand the role of Hst-1/FGF-4 in mouse limb development, an antisense oligodeoxynucleotides (ODNs) study was performed. We first established a novel organ culture system to study mouse limb development in vitro. This system allows mouse limb bud at 9.5-10-d p.c. embryo, when placed on a sheet of extracellular matrix in a defined medium, to differentiate into a limb at 12.5-d p.c. embryo within 4.5 d. Using this organ culture system, we have shown that exposure of 9.5-10-d p.c. embryonal limb bud explants to antisense ODNs of Hst-1/FGF-4 blocks limb development. In contrast, sense and scrambled ODNs have no inhibitory effect on limb outgrowth, suggesting that Hst-1/FGF-4 may work as a potent inducing factor for mouse limb development.

Indexed as

AnimalsBase SequenceBlotting, NorthernDissectionEmbryonic InductionExtremitiesFibroblast Growth Factor 4Fibroblast Growth Factor 8Fibroblast Growth FactorsForelimbGrowth SubstancesHindlimbMiceMice, Inbred ICRMolecular Sequence DataMorphogenesisFgf4 protein, mouseFgf8 protein, mouseFibroblast Growth Factor 4Fibroblast Growth Factor 8Fibroblast Growth FactorsGrowth SubstancesNeoplasm ProteinsOligonucleotides, AntisenseProto-Oncogene ProteinsRNA, Messenger

Identifiers

PMID7642715
PMCPMC2199953
OpenAlexW1964489641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.